Anxiolytics like benzodiazepines or SSRIs can modulate neurotransmitter activity in Visual Snow Syndrome by reducing glutamatergic hyperexcitability and enhancing GABAergic inhibition in cortical and thalamic circuits. These medications may help mitigate neurological hyperactivity and reduce the perceptual disturbances associated with the syndrome by stabilizing neural network functioning and potentially dampening aberrant sensory processing.